Paper16734731
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
Miyoshi Y and 7 others. Cancer Sci, 2006. Cited by 89 papers, by iCite.
Cite this record
ConductScience Library. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Papers, record 16734731. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16734731
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Biomarkers, Tumor | Major topic |
| Breast Neoplasms | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Ubiquitin Thiolesterase | Major topic |
| Antigens, CD | |
| Female | |
| Humans | |
| Postmenopause | |
| Premenopause | |
| Prognosis | |
| RNA, Messenger | |
| Receptors, Estrogen | |
| Receptors, Progesterone | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9865724 | Serial analysis of gene expression in non-small cell lung cancer. | Cancer Res | 1998 | https://conductscience.org/library/papers/9865724 | PubMed |
| 2 | 15491288 | Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells. | Br J Haematol | 2004 | https://conductscience.org/library/papers/15491288 | PubMed |
| 3 | 2551477 | Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. | Cancer | 1989 | https://conductscience.org/library/papers/2551477 | PubMed |
| 4 | 9521656 | Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. | Biochemistry | 1998 | https://conductscience.org/library/papers/9521656 | PubMed |
| 5 | 1426603 | Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases. | Biochem Soc Trans | 1992 | https://conductscience.org/library/papers/1426603 | PubMed |
| 6 | 9614804 | Adjuvant Therapy of Primary Breast Cancer, 6th International Conference. Olma Messen St. Gallen. February 25-28, 1998. Abstracts. | Eur J Cancer | 1998 | https://conductscience.org/library/papers/9614804 | PubMed |
| 7 | 12507557 | Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system. | Semin Cancer Biol | 2003 | https://conductscience.org/library/papers/12507557 | PubMed |
| 8 | 10713173 | Expression and functional analysis of Uch-L3 during mouse development. | Mol Cell Biol | 2000 | https://conductscience.org/library/papers/10713173 | PubMed |
| 9 | 11801558 | PGP9.5 as a marker for invasive colorectal cancer. | Clin Cancer Res | 2002 | https://conductscience.org/library/papers/11801558 | PubMed |
| 10 | 11773260 | Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer. | Jpn J Clin Oncol | 2001 | https://conductscience.org/library/papers/11773260 | PubMed |
| 11 | 12408865 | The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. | Cell | 2002 | https://conductscience.org/library/papers/12408865 | PubMed |
| 12 | 8541094 | Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer. | Eur J Cancer | 1995 | https://conductscience.org/library/papers/8541094 | PubMed |
| 13 | 9018245 | Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. | Nat Med | 1997 | https://conductscience.org/library/papers/9018245 | PubMed |
| 14 | 9472642 | The ubiquitin-proteasome pathway in cancer. | Br J Cancer | 1998 | https://conductscience.org/library/papers/9472642 | PubMed |
| 15 | 14571718 | PGP9.5 overexpression in esophageal squamous cell carcinoma. | Hepatogastroenterology | 2003 | https://conductscience.org/library/papers/14571718 | PubMed |
| 16 | 9018244 | Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. | Nat Med | 1997 | https://conductscience.org/library/papers/9018244 | PubMed |
| 17 | 12082530 | Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1). | Oncogene | 2002 | https://conductscience.org/library/papers/12082530 | PubMed |
| 18 | 2530630 | The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. | Science | 1989 | https://conductscience.org/library/papers/2530630 | PubMed |
| 19 | 11158620 | Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11158620 | PubMed |
| 20 | 14962731 | PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma. | Eur J Cancer | 2004 | https://conductscience.org/library/papers/14962731 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41945287 | UCHL3 Promotes Triple-Negative Breast Cancer Metastatic Potential Through Enhancing Cell Migration and Invasion. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/41945287 | PubMed |
| 41578740 | Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease. | Brain | 2026 | https://conductscience.org/library/papers/41578740 | PubMed |
| 41271634 | UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41271634 | PubMed |
| 40691601 | UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40691601 | PubMed |
| 40141757 | Proteasomes and Ubiquitin C-Terminal Hydrolase L1 as Biomarkers of Tissue Damage and Inflammatory Response to Different Types of Injury-A Short Review. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40141757 | PubMed |
| 39005671 | Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. | Am J Cancer Res | 2024 | https://conductscience.org/library/papers/39005671 | PubMed |
| 36844618 | Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review). | Oncol Lett | 2023 | https://conductscience.org/library/papers/36844618 | PubMed |
| 36142702 | Structural Insights into the Phosphorylation-Enhanced Deubiquitinating Activity of UCHL3 and Ubiquitin Chain Cleavage Preference Analysis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36142702 | PubMed |
| 34745437 | UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells. | Anim Cells Syst (Seoul) | 2021 | https://conductscience.org/library/papers/34745437 | PubMed |
| 34539860 | UCHL3 plays an important role in the occurrence and development of melanoma. | Oncol Lett | 2021 | https://conductscience.org/library/papers/34539860 | PubMed |
| 34497382 | UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology. | Br J Cancer | 2022 | https://conductscience.org/library/papers/34497382 | PubMed |
| 33995103 | Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/33995103 | PubMed |
| 33668938 | Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1. | Molecules | 2021 | https://conductscience.org/library/papers/33668938 | PubMed |
| 33585209 | Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585209 | PubMed |
| 33438509 | UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo. | Am J Physiol Lung Cell Mol Physiol | 2021 | https://conductscience.org/library/papers/33438509 | PubMed |
| 32656641 | Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion. | J Neurol | 2020 | https://conductscience.org/library/papers/32656641 | PubMed |
| 32546741 | The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32546741 | PubMed |
| 32042339 | UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer. | Theranostics | 2020 | https://conductscience.org/library/papers/32042339 | PubMed |
| 31906456 | Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/31906456 | PubMed |
| 31598398 | UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization. | Am J Cancer Res | 2019 | https://conductscience.org/library/papers/31598398 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| UCHL1 | 7345 | PubTator's text mining | https://conductscience.org/library/genes/7345 | NCBI Gene |
| UCHL3 | 7347 | PubTator's text mining | https://conductscience.org/library/genes/7347 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16734731
GET https://conductscience.org/api/papers/v1/16734731/references?page=2